Drug Shortages and Patient Care Impact

Drug shortages have emerged as a pressing global health challenge, affecting all therapeutic classes from life-saving oncology agents and antimicrobials to cardiovascular and anaesthetic drugs. These shortages arise from an interplay of manufacturing disruptions, raw-material scarcities, logistical bottlenecks and variable regulatory frameworks. Unpredictable demand spikes—exemplified by pandemics or seasonal surges—further strain already fragile supply chains. The consequences for patient care are profound: delayed or omitted treatments, increased medication errors, adverse health outcomes and heightened financial burdens on healthcare systems and individuals. Moreover, shortages pose ethical dilemmas for clinicians who must ration scarce resources or select less familiar alternatives. In response, health authorities have pursued early warning systems, mandated reporting obligations, strategic stockpiles and collaborative frameworks that unite manufacturers, distributors and care providers. At the frontline, hospital pharmacists and procurement officers invest considerable effort in sourcing substitutes, adapting inventory protocols and liaising with regulatory bodies to safeguard continuity of care. The global nature of modern pharmaceutical supply chains underscores the need for harmonised definitions, interoperable data platforms and resilient procurement networks to anticipate disruptions and protect patient welfare.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Drug Shortages and Patient Care Impact publication trend

The graph below shows the total number of articles in drug shortages and patient care impact across all publications each year (not limited to Nature Index journals).

Technical terms

Drug shortage: A situation in which the supply of a medicine or dosage form does not meet clinical demand at the patient level.

Supply chain: The network of manufacturers, distributors, wholesalers and healthcare providers involved in delivering medicines to patients.

Mitigation strategies: Organised actions, such as policy reform, operational adjustments and alternative sourcing, designed to prevent or alleviate drug shortages.

Essential medicines: Drugs considered fundamental for addressing the priority health needs of a population, as determined by global or national health authorities.

References

1. Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in Pharmacology (2021).
2. The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia. Healthcare (2021).
3. Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications. BMC Health Services Research (2020).